QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives of Formula I. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DARCY, MICHAEL GERARD NEWLANDER, KENNETH ALLEN BURGESS, JOELLE LORRAINE SARPONG, MARTHA DONATELLI, CARLA A RIDGERS, LANCE KNIGHT, STEVEN DAVID SCHMIDT, STANLEY J ADAMS, NICHOLAS D |
description | Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives of Formula I. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. (see formula I) |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2686016C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2686016C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2686016C3</originalsourceid><addsrcrecordid>eNrjZNALDPX08_fx9HNVcHEN8gxzDPEMcw1WcAxWCPA0VvD29HMMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORmYWZgaGZs7GhFUAAFd1JOU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS</title><source>esp@cenet</source><creator>DARCY, MICHAEL GERARD ; NEWLANDER, KENNETH ALLEN ; BURGESS, JOELLE LORRAINE ; SARPONG, MARTHA ; DONATELLI, CARLA A ; RIDGERS, LANCE ; KNIGHT, STEVEN DAVID ; SCHMIDT, STANLEY J ; ADAMS, NICHOLAS D</creator><creatorcontrib>DARCY, MICHAEL GERARD ; NEWLANDER, KENNETH ALLEN ; BURGESS, JOELLE LORRAINE ; SARPONG, MARTHA ; DONATELLI, CARLA A ; RIDGERS, LANCE ; KNIGHT, STEVEN DAVID ; SCHMIDT, STANLEY J ; ADAMS, NICHOLAS D</creatorcontrib><description>Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives of Formula I. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. (see formula I)</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150421&DB=EPODOC&CC=CA&NR=2686016C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150421&DB=EPODOC&CC=CA&NR=2686016C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DARCY, MICHAEL GERARD</creatorcontrib><creatorcontrib>NEWLANDER, KENNETH ALLEN</creatorcontrib><creatorcontrib>BURGESS, JOELLE LORRAINE</creatorcontrib><creatorcontrib>SARPONG, MARTHA</creatorcontrib><creatorcontrib>DONATELLI, CARLA A</creatorcontrib><creatorcontrib>RIDGERS, LANCE</creatorcontrib><creatorcontrib>KNIGHT, STEVEN DAVID</creatorcontrib><creatorcontrib>SCHMIDT, STANLEY J</creatorcontrib><creatorcontrib>ADAMS, NICHOLAS D</creatorcontrib><title>QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS</title><description>Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives of Formula I. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. (see formula I)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNALDPX08_fx9HNVcHEN8gxzDPEMcw1WcAxWCPA0VvD29HMMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORmYWZgaGZs7GhFUAAFd1JOU</recordid><startdate>20150421</startdate><enddate>20150421</enddate><creator>DARCY, MICHAEL GERARD</creator><creator>NEWLANDER, KENNETH ALLEN</creator><creator>BURGESS, JOELLE LORRAINE</creator><creator>SARPONG, MARTHA</creator><creator>DONATELLI, CARLA A</creator><creator>RIDGERS, LANCE</creator><creator>KNIGHT, STEVEN DAVID</creator><creator>SCHMIDT, STANLEY J</creator><creator>ADAMS, NICHOLAS D</creator><scope>EVB</scope></search><sort><creationdate>20150421</creationdate><title>QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS</title><author>DARCY, MICHAEL GERARD ; NEWLANDER, KENNETH ALLEN ; BURGESS, JOELLE LORRAINE ; SARPONG, MARTHA ; DONATELLI, CARLA A ; RIDGERS, LANCE ; KNIGHT, STEVEN DAVID ; SCHMIDT, STANLEY J ; ADAMS, NICHOLAS D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2686016C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DARCY, MICHAEL GERARD</creatorcontrib><creatorcontrib>NEWLANDER, KENNETH ALLEN</creatorcontrib><creatorcontrib>BURGESS, JOELLE LORRAINE</creatorcontrib><creatorcontrib>SARPONG, MARTHA</creatorcontrib><creatorcontrib>DONATELLI, CARLA A</creatorcontrib><creatorcontrib>RIDGERS, LANCE</creatorcontrib><creatorcontrib>KNIGHT, STEVEN DAVID</creatorcontrib><creatorcontrib>SCHMIDT, STANLEY J</creatorcontrib><creatorcontrib>ADAMS, NICHOLAS D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DARCY, MICHAEL GERARD</au><au>NEWLANDER, KENNETH ALLEN</au><au>BURGESS, JOELLE LORRAINE</au><au>SARPONG, MARTHA</au><au>DONATELLI, CARLA A</au><au>RIDGERS, LANCE</au><au>KNIGHT, STEVEN DAVID</au><au>SCHMIDT, STANLEY J</au><au>ADAMS, NICHOLAS D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS</title><date>2015-04-21</date><risdate>2015</risdate><abstract>Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives of Formula I. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. (see formula I)</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2686016C |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A44%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DARCY,%20MICHAEL%20GERARD&rft.date=2015-04-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2686016C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |